243 related articles for article (PubMed ID: 29409973)
21. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway.
Chen E; Huang J; Chen M; Wu J; Ouyang P; Wang X; Shi D; Liu Z; Zhu W; Sun H; Yang S; Zhang B; Deng W; Qiu H; Xie F
J Transl Med; 2023 Feb; 21(1):134. PubMed ID: 36814284
[TBL] [Abstract][Full Text] [Related]
22. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
[TBL] [Abstract][Full Text] [Related]
23. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
[TBL] [Abstract][Full Text] [Related]
24. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
[TBL] [Abstract][Full Text] [Related]
25. BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.
Chiu YH; Lee JY; Cantley LC
Mol Cell; 2014 Apr; 54(1):193-202. PubMed ID: 24657164
[TBL] [Abstract][Full Text] [Related]
26. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway.
Wen L; Ding Y; Chen X; Tian K; Li D; Liang K; Yue B
Biomed Res Int; 2021; 2021():9917365. PubMed ID: 34604387
[TBL] [Abstract][Full Text] [Related]
27. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 Induces Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway.
Fei Z; Deng Z; Zhou L; Li K; Xia X; Xie R
Oncol Res; 2019 Jul; 27(7):801-807. PubMed ID: 30982497
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Zhang W; Li L; Guo E; Zhou H; Ming J; Sun L; Hu G; Zhang L
Head Neck; 2022 Jul; 44(7):1576-1587. PubMed ID: 35394102
[TBL] [Abstract][Full Text] [Related]
30. Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated
Li M; Liu Y; Wei Y; Wu C; Meng H; Niu W; Zhou Y; Wang H; Wen Q; Fan S; Li Z; Li X; Zhou J; Cao K; Xiong W; Zeng Z; Li X; Qiu Y; Li G; Zhou M
J Biol Chem; 2019 Apr; 294(15):6172-6187. PubMed ID: 30718276
[TBL] [Abstract][Full Text] [Related]
31. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma.
Yu X; Zhen Y; Yang H; Wang H; Zhou Y; Wang E; Marincola FM; Mai C; Chen Y; Wei H; Song Y; Lyu X; Ye Y; Cai L; Wu Q; Zhao M; Hua S; Fu Q; Zhang Y; Yao K; Liu Z; Li X; Fang W
Cell Death Dis; 2013 May; 4(5):e634. PubMed ID: 23681229
[TBL] [Abstract][Full Text] [Related]
32. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma.
Zhao Y; Yang L; He J; Yang H
Tumour Biol; 2017 Jul; 39(7):1010428317711644. PubMed ID: 28720063
[TBL] [Abstract][Full Text] [Related]
33. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway.
Zhang J; Zhou J; Xiao S
Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369
[TBL] [Abstract][Full Text] [Related]
34. MiR-122 exerts anti-proliferative and apoptotic effects on nasopharyngeal carcinoma cells via the PI3K/AKT signaling pathway.
Cheng C; Xiaohua W; Ning J; Dan Z; Chengyun Y; Lijun Z; Li Y; Shengfu H; Hong J; He X
Cell Mol Biol (Noisy-le-grand); 2018 Oct; 64(13):21-25. PubMed ID: 30403591
[TBL] [Abstract][Full Text] [Related]
35. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
36. SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma.
Li Y; Lv Y; Cheng C; Huang Y; Yang L; He J; Tao X; Hu Y; Ma Y; Su Y; Wu L; Yu G; Jiang Q; Liu S; Liu X; Liu Z
Cell Death Dis; 2020 Jul; 11(7):509. PubMed ID: 32641685
[TBL] [Abstract][Full Text] [Related]
37. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
[TBL] [Abstract][Full Text] [Related]
38. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
Li W; Ma H; Liu M
Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
[TBL] [Abstract][Full Text] [Related]
39. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma.
Liu J; Zhu M; Feng Y; Tang Q; Xu M
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400857
[TBL] [Abstract][Full Text] [Related]
40. Ovatodiolide suppresses inflammatory response in BEAS-2B cells by regulating the CREB/AQP5 pathway, and sensitizes nasopharyngeal carcinoma cells to radiation therapy.
Liu SC; Huang CM; Chang YL; Bamodu OA; Yeh CT; Wang HW; Lee FP; Lin CS
Eur J Pharmacol; 2019 Sep; 859():172548. PubMed ID: 31323224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
